News published on: October 8, 2019

BIO Latin America, held on September 3rd and 4th in São Paulo, gathered over 670 experts from 28 countries to discuss the trending topics for the sector and to showcase the innovation under development in the region.


SÃO PAULO, SEPTEMBER 2019 – The fifth edition of the BIO Latin America Conference provided participants the opportunity to establish professional ties and further develop the life sciences and biotechnology industry on the Latin American region. The event is part of BIO’s global portfolio of conferences hosted to drive innovation and stimulate the development of solutions for the sector on the most important and current themes.

Always built from the latest researches that are designing how the sector will unfold a few years from now, the 2019 BIO Latin America Conference focused on emerging biotechnologies and their potential to cure and transform healthcare, including personalized medicine, AI and machine learning, along with recent debates about biodiversity and the use of cannabis for healthcare innovation. 

On a stage that covered two simultaneous panel tracks, that made it possible for participants to follow as much as they could on the 16 thematic sessions held, the discussions also included topics such as international cooperation, corporate venture for biotech and healthcare, the presentation of innovative technologies and success stories on accelerating startups in Latin America.

Furthermore, 805 face-to-face meetings occurred during the event, scheduled through the BIO One-on-One Partnering™ system, fostering business development partnerships between the strategic players gathered at the event.

Mr. Eduardo Emrich, President and CEO at Biominas Brasil, and Mr. Justin Pine, Director of International Affairs at BIO, highlighted the opportunity that the event offers for cooperation between the various actors in the biotechnology and life sciences segment.



With a drive on promoting innovative technologies, the conference also featured the Innovation Arena, showcasing over 30 exhibitors, including 24 startups accelerated by Biominas. Participants included Janssen, Panarea Partners/Uruguay XXI, Brazilian Biodiversity Information System (SiBBr), Alnylam, Synova Health, Fiocruz,  Azidus, Dycem, Macrogen, and Procelys.

The Innovation Arena set the stage for two competitions: the Demoday of the BioStartup Academy 1st class and the Startup Stadium. At each competition, the 5 top startups of each program presented their pitch. The Brazilian startup “YLive” – dedicated to developing biotechnological solutions for animal nutrition, health and microbiota manipulation – was victorious at the Demoday of the BioStartup Academy 1st class; and the Puerto Rican startup “Isla Pharmaceuticals” – that is developing products for the prevention and treatment of mosquito borne illnesses (e.g.: Dengue) – was the winner of the Startup Stadium.



“Life Sciences in Brazil – The Impacts of Technology and Regulation”

Also within its programming, BIO Latin America 2019 witnessed the launch of a u